Alliance Pharma plc, the emerging speciality pharmaceutical company, today announced that it has appointed Michael Gatenby, aged 59, as non-executive chairman.

Michael developed a successful career in finance, being a director of Hill Samuel and Co and Vice Chairman of Charterhouse Bank. Michael graduated with Honours in Law from Cambridge in 1966 and qualified as a chartered accountant in 1969.  He is currently a director of Johnson Service Group Plc, Porvair Plc, SRS Technology Group Plc, Protherics Plc (formerly Proteus International plc) and Cobra Biomanufacturing Plc.  He is also a Trustee/Director of the Stroke Association.

Michael Gatenby's previous directorships in the past five years have been with Bridport plc, SGB Group plc, Powell Duffryn plc as vice chairman and Tarmac plc.

There are no further matters to be disclosed in accordance with paragraph 'f' of schedule 2 of the AIM rules.

John Dawson, CEO of Alliance Pharma commented:

'It is great news for Alliance that Michael has agreed to join the Board.  He brings with him extremely strong City credentials as well as considerable experience in the pharma and biotech areas and he will be able to contribute enormously to our development.'

- ends -

For further information please contact:

Alliance  Pharmaceuticals Ltd

John Dawson
Managing Director
01249 466966

Beattie Financial
James Chandler/Mike Wort/John Moriarty
020 7398 3300